Business Context and Reporting Period
This Form 8-K Current Report was filed by Molina Healthcare, Inc. on May 29, 2018, regarding an event that occurred on May 25, 2018. The filing addresses corporate governance changes specifically related to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the election of a new director to the Board of Directors:
- Appointment: Richard Zoretic was elected as a Class II director.
- Effective Date: August 1, 2018.
- Term: Expires at the Company's 2019 annual meeting.
- Committee Assignments: As of the election date, Mr. Zoretic had not been named to any Board committees.
Management Commentary and Background
The filing provides a detailed professional background for the new director, Richard Zoretic, highlighting his extensive experience in the healthcare sector:
- Recent Experience: Retired in May 2014 as Executive Vice President of WellPoint, Inc. and President of its Government Business Division (covering Medicare, Medicaid, and Federal Employee Program).
- Prior Leadership: Previously served as Executive Vice President and Chief Operating Officer of Amerigroup Corporation, overseeing health plan operations, provider networks, and technology.
- Earlier Career: Held senior leadership positions at UnitedHealth Group and MetLife Group, and served as a management consultant at Deloitte Consulting.
The Company confirmed there are no arrangements or understandings regarding Mr. Zoretic's selection that would require reporting under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the effective start date of Richard Zoretic's directorship (August 1, 2018).
- Confirm the expiration date of the Class II director term (2019 annual meeting).
- Review the attached press release (Exhibit 99.1) for additional details on the Board's rationale for the appointment.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.